HeMemics Overview
- Status
-
Private
- Employees
-
10

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$4.5M
- Investors
-
5
HeMemics General Information
Description
Developer of a biosensor company designed to bring handheld, lab-quality testing performance wherever needed. The company's platform consists of a low-cost, handheld reader and a disposable biosensor that contains up to thirty-two pathogens using patented desiccation technology, enabling clients with the tools required for prompt and informed decision-making, and fostering a safer, healthier world.
Contact Information
Website
www.hememics.comCorporate Office
- 401 Professional Drive
- Suite 220
- Gaithersburg, MD 20879-3445
- United States
Corporate Office
- 401 Professional Drive
- Suite 220
- Gaithersburg, MD 20879-3445
- United States
HeMemics Timeline
HeMemics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Seed Round | 05-Sep-2023 | $4.5M | Completed | Product Development | ||
8. Seed Round | 25-May-2023 | Completed | Product Development | |||
7. Secondary Transaction - Private | Completed | Product Development | ||||
6. Seed Round | 31-Dec-2020 | Completed | Product Development | |||
5. Seed Round | 09-Nov-2018 | Completed | Product Development | |||
4. Angel (individual) | 25-May-2018 | Completed | Startup | |||
3. Seed Round | 18-Dec-2017 | Completed | Startup | |||
2. Accelerator/Incubator | 01-Dec-2017 | Completed | Startup | |||
1. Grant | 01-Jan-2012 | $185K | Completed | Startup |
HeMemics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed 2 | ||||||||
Seed 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
HeMemics Comparisons
Industry
Financing
Details
HeMemics Competitors (5)
One of HeMemics’s 5 competitors is Co-Diagnostics, a Formerly VC-backed company based in Salt Lake City, UT.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Co-Diagnostics | Formerly VC-backed | Salt Lake City, UT | ||||
Grip Molecular | Venture Capital-Backed | Saint Paul, MN | ||||
Lucira Health | Formerly VC-backed | Emeryville, CA | ||||
GrapheneDx | Private Equity-Backed | Boston, MA | ||||
Orasure Technologies | Corporate Backed or Acquired | Bethlehem, PA |
HeMemics Patents
HeMemics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4526680-A2 | Multiplex biosensor for rapid point-of-care diagnostics | Pending | 16-May-2022 | ||
EP-4150331-A1 | Multiplex biosensor for rapid point-of-care diagnostics | Pending | 15-May-2020 | ||
EP-4150331-A4 | Multiplex biosensor for rapid point-of-care diagnostics | Pending | 15-May-2020 | ||
US-20230194520-A1 | Multiplex biosensor for rapid point-of-care diagnostics | Pending | 15-May-2020 | ||
EP-3861330-A1 | Biosensors using carbon nanotubes and an electronic reader for use with the biosensors | Inactive | 05-Oct-2018 | G01N27/4146 |
HeMemics Signals
HeMemics Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
DMV Angel Group | Angel Group | Minority | ||
TEDCO | Venture Capital | Minority | ||
American Vietnamese Investment Partners | Venture Capital | Minority | ||
Inova Health System | Corporation | Minority | ||
U.S. Department of Health and Human Services | Government |
HeMemics FAQs
-
Where is HeMemics headquartered?
HeMemics is headquartered in Gaithersburg, MD.
-
What is the size of HeMemics?
HeMemics has 10 total employees.
-
What industry is HeMemics in?
HeMemics’s primary industry is Diagnostic Equipment.
-
Is HeMemics a private or public company?
HeMemics is a Private company.
-
What is HeMemics’s current revenue?
The current revenue for HeMemics is
. -
How much funding has HeMemics raised over time?
HeMemics has raised $10.2M.
-
Who are HeMemics’s investors?
DMV Angel Group, TEDCO, American Vietnamese Investment Partners, Inova Health System, and U.S. Department of Health and Human Services have invested in HeMemics.
-
Who are HeMemics’s competitors?
Co-Diagnostics, Grip Molecular, Lucira Health, GrapheneDx, and Orasure Technologies are competitors of HeMemics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »